The Effects of pregnenolone 16α-carbonitrile dosing on digoxin pharmacokinetics and intestinal absorption in the rat

Simon Lowes, Iain S. Haslam, Britt Marie Fihn, Constanze Hilgendorf, Johan E. Karlsson, Nicholas L. Simmons, Anna Lena Ungell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The effect of Pgp induction in rats by pregnenolone 16α-carbonitrile (PCN) (3 days, 35 mg/kg/d, p.o.) on digoxin pharmacokinetics and intestinal transport has been assessed. After intravenous or oral digoxin dosing the arterial and hepatic portal vein (oral) AUC (0-24h) were significantly reduced by PCN pre-treatment. Biliary digoxin clearance increased 2-fold following PCN treatment. PCN significantly increased net digoxin secretion (2.05- and 4.5-fold respectively) in ileum and colon but not in duodenum or jejunum. This increased secretion correlated with increased Pgp protein expression in ileum and colon. Both intestinal and biliary excretion therefore contribute to altered digoxin disposition following PCN. © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.
    Original languageEnglish
    Pages (from-to)61-77
    Number of pages16
    JournalPharmaceutics
    Volume2
    Issue number1
    DOIs
    Publication statusPublished - Mar 2010

    Keywords

    • ABCB1
    • ATP-binding cassette
    • Digoxin
    • Disposition
    • Induction
    • Intestinal ransport
    • P-glycoprotein
    • Pharmacokinetics
    • Pregnane X receptor
    • Pregnenolone 16α-carbonitrile

    Fingerprint

    Dive into the research topics of 'The Effects of pregnenolone 16α-carbonitrile dosing on digoxin pharmacokinetics and intestinal absorption in the rat'. Together they form a unique fingerprint.

    Cite this